AMA To Support Increased Resources For TB Control
Main Category: TuberculosisAlso Included In: Respiratory / Asthma; Aid / Disasters; Public Health
Article Date: 28 Jun 2007 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The AMA today voted to support federal legislation to increase resources for global and domestic tuberculosis (TB) control.
"About one-third of the world's population is infected with tuberculosis, and drug resistant strains of TB are spreading around the world," said J. James Rohack, M.D., AMA board member. "About 10-14 million Americans are infected with latent TB. With the newest class of anti-TB drugs over 40 years old and the increase in multi-drug resistance, we need new tools to fight this killer disease."
American Medical Association
http://www.ama-assn.org
Visit our tuberculosis section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/75487.php>
APA
http://www.medicalnewstoday.com/releases/75487.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



